C2616 is the HCPCS Level II device code (often searched as CPT C2616) for: Brachytherapy source, non-stranded, yttrium-90, per source. No public Medicare dataset shows who bills C2616: this class of device code never appears as its own paid line in Medicare's public claims files.
C2616 is a brachytherapy source (OPPS status indicator U) on APC 2616: Medicare pays hospitals $17,771.01 per source (2026 OPPS). In ambulatory surgical centers it is a brachytherapy source: paid separately at the OPPS rate.
No public CMS dataset carries C2616 utilization, at any grain. It is paid separately at OPPS rates, but facility claims are published only at APC grain, so the code never appears as its own line in any public file. The Medicare-visible side is the procedure, not the source.
Per-claim C-code detail exists only in restricted CMS research files that can't be used in a commercial product. So any site offering a "C2616 top billers" list is showing you something other than real data. We'd rather show you what actually exists: the procedures below are where this device shows up in Medicare's public data, and each one has a real who-bills answer.
New to this code class? Read how C-codes are reimbursed.
The device is invisible in the claims data. The procedures it's used in are not: each row below is public 2024 Medicare data.
| Code | Procedure (CMS description) | Providers (2024) | Services | |
|---|---|---|---|---|
| 37243 | Occlusion of growths or obstructed vessels with review by… | 322 | 10,658 | |
| 79445 | Radioactive drug therapy through a tube inserted in an… | 63 | 1,174 |
Device makers in this space disclose payments to clinicians under the Sunshine Act: state-by-state industry payments →
Prospect 811 maps who performs the procedures your device rides with: in your exact territory, ranked, with phone numbers. $79/month, no contract, 14-day refund.
Start prospecting →